$CRTG
CORETEC GROUP INC.

2020 Q2 Form 10-Q Financial Statement

#000143774920010917 Filed on May 15, 2020

View on sec.gov

Income Statement

Concept 2020 Q2 2020 Q1 2019 Q1
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $212.9K $289.8K $184.9K
YoY Change 24.99% 56.74% -15.95%
% of Gross Profit
Research & Development $36.10K $43.89K $20.06K
YoY Change 79.97% 118.85% -4.12%
% of Gross Profit
Depreciation & Amortization $20.06K $126.00 $189.00
YoY Change -0.89% -33.33% -0.53%
% of Gross Profit
Operating Expenses $36.10K $43.89K $20.06K
YoY Change 79.97% 118.85% -4.12%
Operating Profit
YoY Change
Interest Expense $56.65K $220.4K $93.37K
YoY Change -40.64% 136.09% -3.08%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$289.6K -$530.3K -$298.3K
YoY Change 1.32% 77.77% -12.26%
Income Tax
% Of Pretax Income
Net Earnings -$289.6K -$530.3K -$298.3K
YoY Change 1.32% 77.76% -11.88%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$1.429K -$2.739K -$4.347K
COMMON SHARES
Basic Shares Outstanding 202.7M 202.7M
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q2 2020 Q1 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $107.8K $80.49K $70.00
YoY Change 218.5% 114885.71% -99.95%
Cash & Equivalents $107.8K $80.49K
Short-Term Investments
Other Short-Term Assets $33.34K $47.52K $26.59K
YoY Change -9.75% 78.71% -11.37%
Inventory
Prepaid Expenses $33.34K $47.52K $26.59K
Receivables
Other Receivables
Total Short-Term Assets $141.1K $128.0K $26.66K
YoY Change 99.37% 380.22% -84.24%
LONG-TERM ASSETS
Property, Plant & Equipment $693.00
YoY Change -52.17%
Goodwill $166.0K $166.0K $166.0K
YoY Change 0.0% 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $3.580K $3.580K $2.320K
YoY Change 54.31% 54.31%
Total Long-Term Assets $1.269M $1.289M $1.368M
YoY Change -5.89% -5.82% -5.59%
TOTAL ASSETS
Total Short-Term Assets $141.1K $128.0K $26.66K
Total Long-Term Assets $1.269M $1.289M $1.368M
Total Assets $1.410M $1.417M $1.395M
YoY Change -0.64% 1.55% -13.81%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $478.2K $557.1K $691.1K
YoY Change -33.55% -19.39% 19.16%
Accrued Expenses $551.1K
YoY Change 67.01%
Deferred Revenue
YoY Change
Short-Term Debt $5.590K $22.37K $81.44K
YoY Change -91.79% -72.53% 16.34%
Long-Term Debt Due $1.821M
YoY Change 31.02%
Total Short-Term Liabilities $483.8K $579.5K $3.145M
YoY Change -85.83% -81.57% 32.08%
LONG-TERM LIABILITIES
Long-Term Debt $186.3K $23.39K $0.00
YoY Change -100.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $186.3K $23.39K $0.00
YoY Change -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $483.8K $579.5K $3.145M
Total Long-Term Liabilities $186.3K $23.39K $0.00
Total Liabilities $670.0K $602.9K $3.145M
YoY Change -80.37% -80.83% 29.96%
SHAREHOLDERS EQUITY
Retained Earnings -$6.314M -$6.025M -$3.938M
YoY Change 49.48% 52.98% 34.32%
Common Stock $40.71K $40.53K $13.74K
YoY Change 191.12% 195.09% 1.61%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $739.8K $813.9K -$1.750M
YoY Change
Total Liabilities & Shareholders Equity $1.410M $1.417M $1.395M
YoY Change -0.64% 1.55% -13.81%

Cashflow Statement

Concept 2020 Q2 2020 Q1 2019 Q1
OPERATING ACTIVITIES
Net Income -$289.6K -$530.3K -$298.3K
YoY Change 1.32% 77.76% -11.88%
Depreciation, Depletion And Amortization $20.06K $126.00 $189.00
YoY Change -0.89% -33.33% -0.53%
Cash From Operating Activities -$295.5K -$324.6K -$75.61K
YoY Change 161.69% 329.38% -76.02%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 322.7K 347.0K 71.68K
YoY Change 120.03% 384.09% -662.3%
NET CHANGE
Cash From Operating Activities -295.5K -324.6K -75.61K
Cash From Investing Activities
Cash From Financing Activities 322.7K 347.0K 71.68K
Net Change In Cash 27.27K 22.35K -3.929K
YoY Change -19.25% -668.72% -98.8%
FREE CASH FLOW
Cash From Operating Activities -$295.5K -$324.6K -$75.61K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q1 crtg Assets Excluding Property And Equipment Noncurrent
AssetsExcludingPropertyAndEquipmentNoncurrent
1288772
CY2019Q4 crtg Assets Excluding Property And Equipment Noncurrent
AssetsExcludingPropertyAndEquipmentNoncurrent
1308830
CY2019 crtg Class Of Warrant Or Right Contractual Term
ClassOfWarrantOrRightContractualTerm
P4Y215D
CY2020Q1 crtg Class Of Warrant Or Right Contractual Term
ClassOfWarrantOrRightContractualTerm
P4Y292D
CY2020Q1 crtg Class Of Warrant Or Right Exercisable
ClassOfWarrantOrRightExercisable
1020000
CY2020Q1 crtg Class Of Warrant Or Right Exercisable Exercise Price
ClassOfWarrantOrRightExercisableExercisePrice
0.052
CY2020Q1 dei Document Period End Date
DocumentPeriodEndDate
2020-03-31
CY2020Q1 dei Document Type
DocumentType
10-Q
CY2020Q1 dei Amendment Flag
AmendmentFlag
false
CY2020Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020Q1 dei Entity Registrant Name
EntityRegistrantName
CORETEC GROUP INC.
CY2020Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001375195
CY2020Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2020Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
202650642
CY2020Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2020Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2020Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2020Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q1 dei Entity Shell Company
EntityShellCompany
false
CY2019Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
570000
CY2020Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1020000
CY2020Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0002
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0002
CY2020Q1 crtg Class Of Warrant Or Right Exercisable Intrinsic Value
ClassOfWarrantOrRightExercisableIntrinsicValue
CY2020Q1 crtg Class Of Warrant Or Right Granted Contractual Term
ClassOfWarrantOrRightGrantedContractualTerm
P5Y
CY2020Q1 crtg Class Of Warrant Or Right Intrinsic Value
ClassOfWarrantOrRightIntrinsicValue
CY2020Q1 crtg Class Of Warrant Or Right Issued During Period Exercise Price
ClassOfWarrantOrRightIssuedDuringPeriodExercisePrice
0.052
CY2020Q1 crtg Class Of Warrant Or Right Issued Monthly
ClassOfWarrantOrRightIssuedMonthly
450000
CY2020Q1 crtg Proceeds From Debt And Warrants Issued
ProceedsFromDebtAndWarrantsIssued
363750
CY2019Q1 crtg Proceeds From Debt And Warrants Issued
ProceedsFromDebtAndWarrantsIssued
85000
CY2019Q1 crtg Stock Issued During Period Value Issued For Liabilities
StockIssuedDuringPeriodValueIssuedForLiabilities
7862
CY2020Q1 crtg Stock Issued To Settle Liabilities From Services Received
StockIssuedToSettleLiabilitiesFromServicesReceived
310303
CY2019Q1 crtg Stock Issued To Settle Liabilities From Services Received
StockIssuedToSettleLiabilitiesFromServicesReceived
CY2020Q1 crtg Stock Options Issued For Accounts Payable
StockOptionsIssuedForAccountsPayable
300000
CY2019Q1 crtg Stock Options Issued For Accounts Payable
StockOptionsIssuedForAccountsPayable
CY2020Q1 crtg Warrant Exercisable Contractual Term
WarrantExercisableContractualTerm
P4Y292D
CY2020Q1 crtg Working Capital Deficit
WorkingCapitalDeficit
474864
CY2020Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
557122
CY2019Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
615815
CY2020Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
6797809
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
6135885
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
310303
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
53447
CY2020Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
202882
CY2019Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
33874
CY2020Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
20057
CY2019Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
20057
CY2020Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
39568882
CY2019Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
301496271
CY2020Q1 us-gaap Assets
Assets
1416784
CY2019Q4 us-gaap Assets
Assets
1455926
CY2020Q1 us-gaap Assets Current
AssetsCurrent
128012
CY2019Q4 us-gaap Assets Current
AssetsCurrent
146970
CY2019Q4 us-gaap Cash
Cash
58149
CY2018Q4 us-gaap Cash
Cash
4001
CY2020Q1 us-gaap Cash
Cash
80494
CY2019Q1 us-gaap Cash
Cash
72
CY2020Q1 us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
22345
CY2019Q1 us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
-3929
CY2019Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.052
CY2020Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.052
CY2020Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1500000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1500000000
CY2020Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
202650642
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
193521506
CY2020Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
202650642
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
193521506
CY2020Q1 us-gaap Common Stock Value
CommonStockValue
40530
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
38704
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1416784
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1455926
CY2020Q1 us-gaap Liabilities Current
LiabilitiesCurrent
579487
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
654953
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
346977
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
71676
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-324632
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-75605
us-gaap Net Income Loss
NetIncomeLoss
6024500
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-530307
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-298323
CY2020Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1119197
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1139255
CY2020Q1 us-gaap Costs And Expenses
CostsAndExpenses
530307
CY2019Q1 us-gaap Costs And Expenses
CostsAndExpenses
298323
CY2020Q1 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
CY2019Q1 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
7862
CY2020Q1 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
3575
CY2019Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
3575
CY2020Q1 us-gaap Depreciation
Depreciation
126
CY2019Q1 us-gaap Depreciation
Depreciation
189
CY2020Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.003
CY2019Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.004
CY2020Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-58693
CY2019Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
157946
CY2020Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-41303
CY2019Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-10652
CY2020Q1 us-gaap Interest Expense
InterestExpense
220439
CY2019Q1 us-gaap Interest Expense
InterestExpense
93370
CY2020Q1 us-gaap Interest Paid Net
InterestPaidNet
18780
CY2019Q1 us-gaap Interest Paid Net
InterestPaidNet
2675
CY2020Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
289811
CY2019Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
184896
CY2020Q1 us-gaap Goodwill
Goodwill
166000
CY2019Q4 us-gaap Goodwill
Goodwill
166000
CY2020Q1 us-gaap Liabilities
Liabilities
602876
CY2019Q4 us-gaap Liabilities
Liabilities
775461
CY2020Q1 us-gaap Notes Payable Current
NotesPayableCurrent
22365
CY2019Q4 us-gaap Notes Payable Current
NotesPayableCurrent
39138
CY2020Q1 us-gaap Notes Payable Related Parties Current And Noncurrent
NotesPayableRelatedPartiesCurrentAndNoncurrent
23389
CY2019Q4 us-gaap Notes Payable Related Parties Current And Noncurrent
NotesPayableRelatedPartiesCurrentAndNoncurrent
120508
CY2020Q1 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
23389
CY2019Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
120508
CY2020Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
8262
CY2019Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
5940
CY2020Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0002
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0002
CY2020Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000
CY2020Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
345000
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
345000
CY2020Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
345000
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
345000
CY2020Q1 us-gaap Preferred Stock Value
PreferredStockValue
69
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
69
CY2020Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
47518
CY2019Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
88821
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
126
CY2020Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
16773
CY2019Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
13324
CY2020Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
20057
CY2019Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
20057
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6024500
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5494193
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
0
CY2020Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
CY2019Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
CY2020Q1 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
21716557
CY2020Q1 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
21716557
CY2020Q1 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
P4Y131D
CY2020Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
300000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
813908
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
680465
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
-1459299
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
-1749760
CY2020Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">Use of Estimates</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses and the disclosure of contingent assets and liabilities. Actual results could differ from the estimates and assumptions used.</div></div></div></div></div></div></div></div></div></div></div></div>
CY2020Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
193621826
CY2019Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
68622677

Files In Submission

Name View Source Status
0001437749-20-010917-index-headers.html Edgar Link pending
0001437749-20-010917-index.html Edgar Link pending
0001437749-20-010917.txt Edgar Link pending
0001437749-20-010917-xbrl.zip Edgar Link pending
crtg-20200331.xml Edgar Link completed
crtg-20200331.xsd Edgar Link pending
crtg-20200331_cal.xml Edgar Link unprocessable
crtg-20200331_def.xml Edgar Link unprocessable
crtg-20200331_lab.xml Edgar Link unprocessable
crtg-20200331_pre.xml Edgar Link unprocessable
crtg20200331_10q.htm Edgar Link pending
ex_186593.htm Edgar Link pending
ex_186594.htm Edgar Link pending
ex_186595.htm Edgar Link pending
ex_186596.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending